临时性血液透析中心静脉留置导管相关性感染的治疗方法比较被引量：3

下载PDF

导出

摘要目的:分析临时性血液透析中心静脉留置导管相关性感染的两种治疗方法,即单纯全身应用抗生素与全身应用抗生素加抗生素封管治疗效果之比较。方法:对因肾衰竭进行中心静脉置管行血液透析的病例共189例进行分析,其中发生导管相关性血流感染病例21例,将其分为A组(对照组)及B组(实验组),其中A组(对照组)10例,单纯静脉应用广谱抗生素头孢米诺2.0g,2次/d静脉滴注或静脉推注。B组(实验组)11例,在静脉应用广谱抗生素头孢米诺2.0g,2次/d静脉滴注或静脉推注同时,给予同种抗生素封管。封管方法:以0.1g/ml头孢米诺1ml加肝素2ml,1次/d封管。两组患者的性别、年龄比较,差异无统计学意义。观察两组治疗效果的差异。结果:实验组与对照组相比,显效率明显提高,复发率低,使疗程缩短。是一种安全有效的治疗中心静脉留置导管相关性感染的方法。结论:抗生素封管联合静脉应用广谱抗生素治疗临时性血液透析中心静脉留置导管相关性血流感染是一种安全、有效的治疗方法。

作者王松岩姚伦李春光

机构地区吉林省人民医院肾内科长春市第二医院

出处《吉林医学》 CAS 2009年第17期1887-1889,共3页 Jilin Medical Journal

关键词血液透析临时性中心静脉导管导管相关性感染治疗

分类号 R472 [医药卫生—护理学]

引文网络
相关文献

参考文献9

1Hoen B,Paul- Dauphin A,Hestin D,et al. EPIBACDIAL: amulticenter prospective study of risk factors for bacteremia in chronic hemodialysis patients [ J ]. J Am Soc Nephrol, 1998,9 (8) : 869.
2Mermel LA, Farr BM, Sherertz R J, et al. Guidelines for the management of intravascular catheter - related infections[ J ]. Clin Infect Dis,2001,32 : 1249.
3曹娅丽,王世相.血液透析患者导管相关性感染的研究现状[J].中国血液净化,2006,5(11):786-789. 被引量：35
4Saxena AK, Panhotra BR, Wahid Uzzaman. The impact of nasal carriage of Staphylococcus aureus on the type of vascular access and dialysis access - related septicemia in elderly [ J ]. Dial Transplant,2003,32( 1 ) :2.
5Adeniyi OA, Tzamaloukas. Relation between access - related infection and pre - infection serum albumin concentration in patients on chronic hemodialysis [ J ]. Hemodial Int, 2003,7 ( 3 ) : 304.
6Saxena AK, Panhotra BR, Naguib M, et al. Septicemia in hemodialysis:A focus on bacterial flora and antibiotic access salvage [ J ]. Saudi J Kidney Dis Transplant,2002,13 ( 1 ) :29.
7Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters[ J]. Am J Kidney Dis, 1999,34 : 1114.
8Beathard GA. Management of bacteremia associated with tunneled- cuffed hemodialysis catheters [ J ].J Am Soc Nephrol, 1999,10:1045.
9Marr KA, Saxton DJ, Conlon PJ, et al.Catheter related bacteremia and outcome attempted catheter salvage in patients undergoing hemodialysis [ J ]. Ann Intern Med, 1997,127:275.

二级参考文献29

1Burr R, Marszalek J, Saul M, et al. The cost of-vascular access infections:Three years experience from a single outpatient dialysis center. Hemodial Int, 2003,7:73-104.
2Liu JW, Su YK, Liu CP, et al. Nosocomial blood-stream infections in patients with end-stage renal disease, excess length of hospital stay, extra cost and attributed mortality. Hosp Infect, 2002,50:224-227.
3Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant, 1999,14:1710-1704.
4Oliver MJ, Callery SM, Thorpe KE, et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:A prospective study. Kidney Int, 2000,58:2543-2545.
5Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis, 1999,34:1114-1124.
6Butterly DW, Schwab SJ. Dialysis access infections, Curr Opin Nephrol Hypertens, 2000,9:631-635.
7Saxena AK, Panhotra BR, Chopra R. Advancing age and risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis. Ann Saudi Med, 2004,24:337-342.
8Saxena AK, Panhotra BR, Wahid Uzzaman. The impact of nasal carriage of Staphylococcus aureus on the type of vascular access and dialysis access-related septicemia in elderly. Dial Transplant, 2003,32:2-10.
9Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients:Incidence, risk factors, and prognosis. Kidney Int, 1999,55:1081.
10De Cicco M, Campisi C, Matovic M. Central venous catheterrelated bloodstream infections:Pathogenesis factors, new perspectives in prevention and early diagnosis. J Vasc Access,2003,4:83-91.